comparemela.com

Sanjeev Ganatra News Today : Breaking News, Live Updates & Top Stories | Vimarsana

MediPrint™ Ophthalmics Announces It Has Initiated Its SIGHT-2 Phase 2b Clinical Study for Its Lead A

Company Also Announces Move into New San Diego HeadquartersSAN DIEGO (BUSINESS WIRE) Today, MediPrint™ Ophthalmics, an emerging San Diego-based clinical stage eye care pharmaceutical company focused on enhancing vision for life, announces it has initiated its SIGHT-2 dose-finding Phase 2b study for its proprietary.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.